Sign in

You're signed outSign in or to get full access.

MW

MIDDLESEX WATER CO (MSEX)·Q4 2024 Earnings Summary

Executive Summary

  • Q4 2024 delivered solid growth: revenue $47.11M and diluted EPS $0.49, up year over year vs Q4 2023 ($38.60M, $0.32), driven by NJBPU base rate increases, weather-driven demand, and interim rates in Delaware .
  • Results beat external Street proxies: EPS $0.49 vs $0.36 consensus and revenue $47.11M vs $45.00M consensus; S&P Global consensus was unavailable, so MarketBeat proxies are shown; the beat was primarily rate and demand-driven .
  • Full-year context: FY 2024 net income $44.4M and diluted EPS $2.47; revenues $191.9M (+$25.6M YoY) with notable one-time recovery of prior-period Park Avenue plant costs and strong demand across systems .
  • 2025–2027 capital plan of $387M (including $93M in 2025 and $105M PFAS treatment at Carl J. Olsen) and Ocean View acquisition approval in Delaware provide medium-term growth visibility .
  • Dividend maintained at $0.34 per share for Q1 2025, extending 52 consecutive years of annual increases, a support for income-oriented holders .

What Went Well and What Went Wrong

What Went Well

  • Strong regulatory outcomes underpin earnings power: NJBPU base rate increase in March 2024 and DE interim rates boosted Q4 and FY results, with management highlighting a constructive regulatory environment .
  • Demand tailwinds: Weather-driven customer demand across regulated systems contributed to Q4 and FY growth, lifting revenue and operating results .
  • Strategic capital deployment: $75M invested in 2024 to enhance resiliency, with a multi-year plan of $387M signaling disciplined infrastructure-led growth .
  • Management quote: “Our strong 2024 performance underscores the strength of our growth strategy… and the trust we have earned from our stakeholders” — CEO Nadine Leslie .

What Went Wrong

  • O&M expenses rose meaningfully: FY 2024 O&M increased $9.3M YoY due to legal/regulatory costs, labor, enhanced treatment processes, and higher energy costs; Q3 had similar drivers (legal, Park Avenue treatment, energy/chemical) .
  • Seasonal normalization vs Q3: Q4 revenue and EPS fell sequentially (Q4 revenue $47.11M vs Q3 $55.10M; EPS $0.49 vs $0.80) reflecting seasonality despite rate benefits .
  • Limited quarterly segment disclosure: While FY system-level revenue increases were disclosed, quarter-by-quarter segment breakdowns were not, reducing visibility into specific drivers by system in Q4 .

Financial Results

MetricQ4 2023Q2 2024Q3 2024Q4 2024
Revenue ($USD Millions)$38.60 $49.15 $55.10 $47.11
Diluted EPS ($USD)$0.32 $0.59 $0.80 $0.49
Operating Income ($USD Millions)$8.24 $15.32 $17.50 $10.53
Operating Income Margin (%)21.4% (8.24/38.60) 31.2% (15.32/49.15) 31.8% (17.50/55.10) 22.4% (10.53/47.11)
Net Income ($USD Millions)$5.77 $10.55 $14.32 $8.80
Net Income Margin (%)14.9% (5.77/38.60) 21.5% (10.55/49.15) 26.0% (14.32/55.10) 18.7% (8.80/47.11)

Segment (FY 2024 revenue change vs FY 2023):

SystemFY 2024 Revenue Change ($USD Millions)
Middlesex System (NJ)+$19.9
Tidewater (DE)+$4.5
Non-regulated+$0.7

KPIs and Capital Program:

KPIFY 2024FY 2025 Plan2025–2027 Plan
Capital Expenditure ($USD Millions)$75 $93 $387 (incl. $105 PFAS treatment at Carl J. Olsen)
Dividend per Share ($USD)$0.34 declared Oct 2024 and maintained into Q1 2025 $0.34 (Q1 2025 declaration) N/A

Estimate comparison (note: S&P Global consensus unavailable):

MetricActual (Q4 2024)Street Consensus (Proxy)Surprise
Diluted EPS ($USD)$0.49 $0.36 (MarketBeat proxy) +$0.13 (Beat)
Revenue ($USD Millions)$47.11 $45.00 (MarketBeat proxy) +$2.11M (Beat)

Guidance Changes

MetricPeriodPrevious GuidanceCurrent GuidanceChange
Capital Expenditure ($USD)FY 2025N/A$93MNew program announced
Infrastructure Investment ($USD)2025–2027N/A$387M totalNew multi-year plan
PFAS Treatment Capital ($USD)2025–2027N/A$105M within plan (Carl J. Olsen plant)New earmark
Dividend per Share ($USD)Q1 2025$0.34 (raised Oct 2024) $0.34 declared Jan 28, 2025Maintained
DE Interim Rate (Annual Rev Impact)Effective Oct 30, 2024N/A~+$2.5M annual (subject to refund)Implemented interim rates
NJ DSIC Filing (Annual Rev Impact)Oct 2024 filingN/A~+$1.1M annual expectedFiled — pending
NJ Purchased Water Adj. ClauseOct 2024 filingN/A+$0.6M cost recovery petitionFiled — pending

Earnings Call Themes & Trends

TopicPrevious Mentions (Q2 2024)Previous Mentions (Q3 2024)Current Period (Q4 2024)Trend
Regulatory outcomes (NJBPU/DEPSC)NJ base rate in March; DE rate case planned Q3 DE interim rates (~$2.5M), NJ DSIC $1.1M, purchased water clause $0.6M Rate increases and interim rates cited as key drivers of Q4/FY results Improving regulatory tailwinds
Customer demand/weatherHigher demand across NJ/DE in 1H Demand boosted Q3 revenues in both systems Weather-driven demand sustained Q4 growth YoY Strong but seasonal normalization
PFAS compliance/treatmentWater for Tomorrow, compliance focus $105M PFAS treatment at Carl J. Olsen in plan Execution ramping
Lead service line inventory (DE)Cost recovery mechanism; $2.1M authorized; $1.7M spent Approved surcharge for costs Not highlighted in Q4 PROngoing program
Capital investment program2024 capex priorities; Park Avenue treatment Continued investments noted $75M in 2024; $93M/2025; $387M/2025–2027 Accelerating multi-year plan
Dividend policy$0.325 declared for Sep 2024 Increased to $0.34 (52nd consecutive year) $0.34 declared for Q1 2025 Stable/increasing trajectory
M&A/footprintDEPSC approved Ocean View acquisition (~900 customers; ~$4.6M) Selective growth added

Management Commentary

  • CEO Nadine Leslie: “Our strong 2024 performance underscores the strength of our growth strategy, the dedication of our team members, a constructive regulatory environment, and the trust we have earned from our stakeholders” .
  • Q3 tone: “Our strong financial results are a reflection of our commitment to operational excellence… and working constructively with regulators to recover prudent infrastructure investments in a timely manner” .
  • Q2 priorities: Focus on growth and succession, investing via RENEW and Water for Tomorrow to meet new federal regulations; DE rate case planned to maintain resiliency and compliance .

Q&A Highlights

  • An earnings call transcript for Q4 2024 was not found in our document catalog or investor site listings; MarketBeat notes a conference call date/time but no transcript content was available. We searched earnings call transcripts and investor site archives and found none .
  • As a result, specific Q&A clarifications on guidance, O&M trajectory, or PFAS project timing were not available from a transcript.

Estimates Context

  • EPS: Actual $0.49 vs consensus proxy $0.36, a beat of +$0.13, driven by NJ base rate increases, weather-driven demand, and DE interim rates; S&P Global consensus was unavailable due to access limitations, so MarketBeat proxies are used .
  • Revenue: Actual $47.11M vs consensus proxy $45.00M, beat of +$2.11M, consistent with demand tailwinds and regulatory actions .
  • Implications: Given sequential seasonal normalization vs Q3, models may recalibrate quarterly seasonality but maintain higher run-rate assumptions for 2025 on rate case impacts and infrastructure-driven O&M, with a watch on PFAS capex deployment .

Key Takeaways for Investors

  • Rate relief plus interim actions in DE and weather-driven demand underpinned a clean beat on EPS and revenue; watch continued regulatory cadence in 2025 for sustained EPS support .
  • Sequential Q4 moderation from Q3 reflects seasonality; the YoY comp remains strong, indicating improved earnings power post-2024 rate actions .
  • Multi-year $387M infrastructure plan (incl. $93M in 2025 and $105M PFAS treatment) signals ongoing capital visibility and potential future rate base growth; monitor regulatory recovery timing .
  • O&M inflation and compliance/treatment costs are a headwind; investors should track cost discipline vs recovery mechanisms (DSIC, surcharges) to protect margins .
  • Dividend durability (52 consecutive years of increases; $0.34 maintained) supports the income thesis; payout underpinned by constructive regulatory outcomes .
  • Selective M&A (Ocean View) adds customers and potential synergies; small but positive footprint expansion .
  • Near-term trading catalysts: PFAS project execution updates, DE rate case progression (interim to final), DSIC approval outcomes, and quarterly demand trends vs seasonality .

Sources

  • Q4/FY 2024 8-K and Exhibit 99.1 press release with consolidated statements .
  • Company press release: “Middlesex Water Company Reports 2024 Financial Results” .
  • Q3 2024 8-K and press release (rate activity, interim rates, dividend increase, financials) .
  • Q2 2024 press release and 8-K (financials, regulatory posture) .
  • Investor site listings for quarterly releases .
  • MarketBeat estimates proxies for Q4 2024 .